Sam-A Pharm Co Ltd
KOSDAQ:009300
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
S
|
Sam-A Pharm Co Ltd
KOSDAQ:009300
|
98.6B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.7B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
292.5B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.2B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
242.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.7B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD |
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
91B GBP |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Sam-A Pharm Co Ltd
Glance View
Sam-A Pharm.Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Wonju, Gangwon-Do. The company went IPO on 2000-07-19. Co., Ltd is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The firm's products include remedies for respiratory, antibiotics, dermatitis treatments, dyspeptic agents, cold remedies, antifebriles, antiphlogistics, analgesics, antihistamines, and remedies for the circulatory, gastrointestinal, urinary systems, cardiovascular and other general pharmaceuticals. The company also provides children nutrition products under the brand name of NOMA.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Sam-A Pharm Co Ltd is 61.2%, which is below its 3-year median of 63.1%.
Over the last 3 years, Sam-A Pharm Co Ltd’s Gross Margin has increased from 60.9% to 61.2%. During this period, it reached a low of 60.9% on Aug 30, 2022 and a high of 64.4% on Jun 30, 2024.
